An observational study in Chronic Regional Pain Syndrome, sponsored by Walton Centre NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Walton Centre NHS Foundation Trust · Observational
Complex regional pain syndrome (CRPS) is a painful and debilitating disorder that usually occurs after limb injury, but can also occur without injury. Persons with CRPS commonly suffer significant levels of disability, loss of function and distress. This in turn can severely compromise a person's quality of life. Guidelines support physiotherapy and occupational therapy treatment for the management of CRPS. It is however not clear from current research as to which particular therapy interventions are most effective. Additionally, the effectiveness of different clinical approaches is poorly reported.
The study aims to establish whether the current therapy treatment offered at the Walton centre for the treatment of CRPS is effective in improving function and activity for people with long-standing complex regional pain syndrome.
Complex regional pain syndrome (CRPS) is a painful and debilitating disorder that usually occurs after limb injury, but can also occur without injury. Typical symptoms specific to the affected limb include; painful changes in skin sensitivity, marked swelling, vivid colour changes, pronounced temperature changes, problems with initiation and control of movement and feelings of disconnection with the affected limb. Persons with CRPS commonly suffer significant levels of disability, loss of function and distress. This in turn can severely compromise a person's quality of life. Guidelines support physiotherapy and occupational therapy treatment for the management of CRPS [3]. It is however not clear from current research as to which particular therapy interventions are most effective. Additionally, the effectiveness of different clinical approaches is poorly reported.
Evidence has emerged to support the use of therapy techniques such as graded motor imagery (GMI) as a treatment approach. GMI involves a three stepped approach to retrain the cortex in respect to aspects of motor control. We have published evidence that demonstrated within clinical practice, this treatment approach alone was not effective in terms reducing pain intensity. Since this publication we have continued to integrate aspects of GMI but moved away from using it as a standalone treatment within therapy outpatient clinics.
Within current therapy sessions the overarching treatment principle is to improve sensory and motor processing in order to promote better movement and function. Initial assessment of patients helps therapists to identify relevant treatment approaches that may influence different aspects of the nervous system in respect to this. For example some patients may present with very heightened and painful skin sensations and therefore desensitising techniques that target peripheral nervous system drivers may be of particular relevance. Whereas patients who present with problems recognising their limb or who struggle to initiate active limb movement may benefit from treatment approaches that target retraining the brain in respect to aspects of motor processing. All patients additionally received education regarding pain mechanisms, flare up management and grading and pacing of activities affected by the condition.
The study aims to establish whether the current therapy treatment within the described clinical setting is effective in improving function and activity for people with long-standing complex regional pain syndrome.
Further aims are to:
This study will analyse already collected data sets and also review patient case notes to obtain further information in respect to therapy treatment, patient demographics and symptom profiles.
206 studies on the registry are indexed under Complex Regional Pain Syndromes; 55 are open to participants now.
This study's enrollment of 90 is above the median of 58 across 44 observational studies indexed under Complex Regional Pain Syndromes.
Browse Complex Regional Pain Syndromes studies →Walton Centre NHS Foundation Trust is the lead sponsor of 17 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with CRPS who have had receipt of treatment at the Walton Centre NHS Foundation Trust
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The Patient-Specific Functional Scale
This questionnaire can be used to quantify activity limitation and measure meaningful changes in activity.
Time frame: From baseline (initial CRPS therapy assessment) to completion of CRPS therapy treatment (up to 4 years)
Patient function
The 'interference with general activity' subscale of the BPI (excluding the walking sub-question in patients affected by CRPS of the upper limb) will be used to assess function
Time frame: From baseline (initial CRPS therapy assessment) to completion of CRPS therapy treatment (up to 4 years)
Pre and post pain intensity
Average and worst post-treatment pain intensity compared with before treatment. This is recorded in the BPI questionnaire on a 0-10 NRS where 0 = 'no pain' and 10 = 'pain as bad as you can imagine'
Time frame: From baseline (initial CRPS therapy assessment) to completion of CRPS therapy treatment (up to 4 years)
Patient Neglect
Measurement of neglect like symptoms will be taken using the Neglect like symptom questionnaire. This questionnaire is used to confirm the presence of neglect-like symptoms in CRPS patients
Time frame: From baseline (initial CRPS therapy assessment) to completion of CRPS therapy treatment (up to 4 years)
Patient quality of life
The EuroQOL-5D-5L measure will be used. Patient perceived global impression of change will be recorded via this questionnaire - this self-report measure reflects a patient's belief about the efficacy of treatment and is widely used in chronic pain clinical trials. Additionally case notes will be reviewed to obtain information regarding condition chronicity, age, gender, medications, details regarding CRPS therapy treatment, number of treatments sessions and discharge outcomes.
Time frame: From baseline (initial CRPS therapy assessment) to completion of CRPS therapy treatment (up to 4 years)
Ran from Nov 2020 to primary completion in May 2023, 29 months.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Complex Regional Pain Syndromes →
Walton Centre NHS Foundation Trust